A biotechnology company serving gene therapy developers is opening a manufacturing facility for engineered viruses that deliver gene therapies. . . . → Read More: Biotech Opens Gene Therapy Manufacturing Facility
|
|||||
|
       
  |
A company designing synthetic DNA and RNA says reference materials are available for tests that detect the quickly spreading Covid-19 delta variant. . . . → Read More: Covid-19 Delta Variant Testing Reference Released 
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds 
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds 
Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals. . . . → Read More: Trial to Test Antibody Drug for Alzheimer’s Prevention 
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds 
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network 
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections. . . . → Read More: Precision Gene-Editing Biotech Gains $200M in New Funds  Comments are closed  Finance, New products  biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, university 
A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr. . . . → Read More: Trial Underway for Crispr Lymphoma Therapy One comment - (Comments are closed) New products biomedical, biotechnology, cancer, clinical trials, genomics, life sciences, university 
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals, university, venture capital |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||